Meyers Steve Lawrence 4
4 · OCULAR THERAPEUTIX, INC · Filed Jan 6, 2026
Insider Transaction Report
Form 4
Meyers Steve Lawrence
Chief Commercial Officer
Transactions
- Award
Common Stock
2026-01-02+64,900→ 217,628 total - Award
Stock Option (Right to Buy)
2026-01-02+197,650→ 197,650 totalExercise: $11.82Exp: 2036-01-01→ Common Stock (197,650 underlying)
Footnotes (2)
- [F1]On January 2, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
- [F2]Subject to the reporting person's continued service to the Corporation, the shares underlying this option vest over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.